Breaking News Instant updates and real-time market news.

GKOS

Glaukos

$59.45

14.66 (32.73%)

12:00
08/29/18
08/29
12:00
08/29/18
12:00

Glaukos rises 32.6%

Glaukos is up 32.6%, or $14.61 to $59.41.

  • 05

    Sep

GKOS Glaukos
$59.45

14.66 (32.73%)

08/29/18
WBLR
08/29/18
NO CHANGE
WBLR
Outperform
CyPass market removal a 'clear positive' for Glaukos, says William Blair
William Blair analyst Brian Weinstein believes Alcon's voluntary global market withdrawal of its CyPass Micro-Stent for surgical glaucoma is a "clear positive for near-term numbers" at Glaukos (GKOS). If Glaukos' iStent takes all of the CyPass market share while it is off the market, the company could add as much as $50M in the U.S. alone to its 2019 total revenue of around $186M, Weinstein tells investors in a research note, while admitting this is a bullish stance. The analyst thinks the news this morning from Alcon should be viewed as a positive for Glaukos, as a major part of the short thesis was on competition in the core iStent market, mainly from Alcon. He keeps an Outperform rating on Glaukos shares.
08/29/18
PIPR
08/29/18
NO CHANGE
Target $55
PIPR
Overweight
Piper sees CyPass withdrawal as 'major boon' for Glaukos, ups target to $55
Piper Jaffray analyst Matt O'Brien views Alcon's immediate withdrawal of its CyPass stent for the treatment of glaucoma on safety concerns from a recently completed clinical study as a "major boon" for Glaukos (GKOS). The analyst suspects it will be several quarters before CyPass comes back to the market, with with a much narrower indication. This is a "major positive" for Glaukos as most of the clinicians using CyPass had been or are still using iStent from Glaukos, O'Brien tells investors in a research note. He anticipates many clinicians will quickly shift their volumes back to iSten, yielding "significant incremental revenues." Based on this morning's news, the analyst raised his price target for Glaukos shares to $55 from $46. He encourages investors to start or build positions in the name.
08/29/18
SPHN
08/29/18
NO CHANGE
Target $57
SPHN
Overweight
Glaukos price target raised to $57 at Stephens after Novartis withdraws CyPass
Stephens analyst Chris Cooley raised his price target on Glaukos (GKOS) shares to $57 from $50 after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. He estimates $40M-$50M in annual sales are now "in play" and see Glaukos as the most likely beneficiary, Cooley tells investors. He maintains an Overweight rating on Glaukos shares, which are up $17.35, or 39%, to $62.15 in pre-market trading.
08/29/18
JPMS
08/29/18
UPGRADE
JPMS
Overweight
Glaukos upgraded to Overweight from Neutral at JPMorgan

TODAY'S FREE FLY STORIES

SHO

Sunstone Hotel

$14.08

-0.32 (-2.22%)

05:23
12/18/18
12/18
05:23
12/18/18
05:23
Downgrade
Sunstone Hotel rating change  »

Sunstone Hotel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.31

-0.46 (-2.59%)

05:21
12/18/18
12/18
05:21
12/18/18
05:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

, S

Sprint

$5.83

-0.14 (-2.35%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Hot Stocks
T-Mobile, Sprint receives approval from CFIUS, Team Telecom »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

S

Sprint

$5.83

-0.14 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$5.76

-0.38 (-6.19%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Downgrade
Washington Prime rating change  »

Washington Prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$39.62

-0.76 (-1.88%)

05:16
12/18/18
12/18
05:16
12/18/18
05:16
Downgrade
Fortune Brands rating change  »

Fortune Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

05:15
12/18/18
12/18
05:15
12/18/18
05:15
General news
FX Action: USD-JPY extended losses »

FX Action: USD-JPY…

SNDR

Schneider National

$19.12

-0.015 (-0.08%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Downgrade
Schneider National rating change  »

Schneider National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$147.63

-3.18 (-2.11%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Upgrade
Norfolk Southern rating change  »

Norfolk Southern upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$95.83

-0.86 (-0.89%)

05:10
12/18/18
12/18
05:10
12/18/18
05:10
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCOI

Cogent

$45.37

-1.25 (-2.68%)

05:07
12/18/18
12/18
05:07
12/18/18
05:07
Upgrade
Cogent rating change  »

Cogent upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$61.50

-2.81 (-4.37%)

05:05
12/18/18
12/18
05:05
12/18/18
05:05
Upgrade
Prologis rating change  »

Prologis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNXF

Cellnex

$0.00

(0.00%)

05:02
12/18/18
12/18
05:02
12/18/18
05:02
Downgrade
Cellnex rating change  »

Cellnex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXST

Nexstar

$84.01

-1 (-1.18%)

, TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

05:00
12/18/18
12/18
05:00
12/18/18
05:00
Recommendations
Nexstar, Tribune Media analyst commentary  »

Nexstar price target…

NXST

Nexstar

$84.01

-1 (-1.18%)

TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$13.46

-0.84 (-5.87%)

04:56
12/18/18
12/18
04:56
12/18/18
04:56
Initiation
Tailored Brands initiated  »

Tailored Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Downgrade
Asos rating change  »

Asos downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIRG

Airgain

$10.70

-0.55 (-4.89%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Airgain management to meet with William Blair »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

CSTM

Constellium

$7.86

0.15 (1.95%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Constellium management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SMLR

Semler Scientific

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Semler Scientific management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 07

    Jan

HSII

Heidrick & Struggles

$32.08

-1.43 (-4.27%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Heidrick & Struggles management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ALSN

Allison Transmission

$42.98

-0.33 (-0.76%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Allison Transmission management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HUN

Huntsman

$18.22

-0.09 (-0.49%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Huntsman management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

EVTC

Evertec

$27.23

-0.16 (-0.58%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Evertec management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PYPL

PayPal

$84.11

-1.82 (-2.12%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
PayPal management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PFE

Pfizer

$43.11

-0.73 (-1.67%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Pfizer management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 05

    Jan

LPSN

LivePerson

$18.62

-0.585 (-3.05%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
LivePerson management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.